13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes

Area of Science:

• Dermatology
• Molecular Biology
• Cell Biology

Background:

• Acne pathophysiology involves sebum production, a process inhibited by isotretinoin (13-cis retinoic acid).
• The precise mechanism of isotretinoin's action on sebocytes remains largely unelucidated.
• Understanding isotretinoin's effects on sebocytes is crucial for acne treatment optimization.

Purpose of the Study:

• To investigate the effects of 13-cis retinoic acid (13-cis RA) and its isomers on sebocyte proliferation, apoptosis, and cell cycle regulation.
• To elucidate the specific molecular pathways involved in 13-cis RA's sebosuppressive activity.
• To determine if 13-cis RA's effects are mediated through retinoid acid receptors (RARs).

Main Methods:

• Treatment of SEB-1 sebocytes and keratinocytes with 13-cis RA, 9-cis RA, and all-trans retinoic acid (ATRA).
• Assessment of cell viability, DNA synthesis, and cell cycle proteins (p21, cyclin D1).
• Induction of apoptosis was measured using Annexin V-FITC, TUNEL staining, and cleaved caspase 3 analysis.
• Evaluation of RAR involvement using a pan-antagonist (AGN 193109).

Main Results:

• 13-cis RA significantly decreased viable SEB-1 sebocytes in a dose- and time-dependent manner.
• Cell cycle arrest was observed, indicated by reduced DNA synthesis, increased p21, and decreased cyclin D1.
• 13-cis RA induced apoptosis in SEB-1 sebocytes, evidenced by increased Annexin V, TUNEL staining, and cleaved caspase 3.
• Apoptosis induction by 13-cis RA was not replicated by 9-cis RA or ATRA and was RAR-independent.

Conclusions:

• 13-cis RA induces SEB-1 sebocyte cell cycle arrest and apoptosis via a RAR-independent pathway.
• These mechanisms contribute to isotretinoin's potent sebosuppressive effect in acne treatment.
• The findings provide novel insights into isotretinoin's molecular mechanism of action.